# OnCo record catalent (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/catalent/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "catalent" ;
  schema:name "Catalent (Novo Holdings)"@en ;
  schema:description "Catalent, of Somerset, New Jersey, is a contract manufacturer that fills and finishes sterile injectables and makes biologics and cell and gene therapies; Novo Holdings bought it in 2024 and moved three sites to Novo Nordisk. The diversion of fill-finish capacity to obesity drugs may squeeze oncology products."@en ;
  schema:url <https://onco.cc/companies/catalent/>, <https://www.catalent.com> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://www.catalent.com> ;
  onco:tag "supporting" ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/adcs/>, <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/sterile-fill-finish/>, <https://onco.cc/technologies/viral-vector-manufacturing/> .